Break Down Barriers to Dispensing Buprenorphine for OUD

March 2025

You play a crucial role in ensuring patients have access to buprenorphine products (Suboxone, etc) for opioid use disorder (OUD).

We know buprenorphine is a first-line treatment for OUD.

But there’s often confusion about regulations...concerns about potential misuse or diversion...and other misconceptions.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Table of Contents

Antipsychotics Consider Metformin to Prevent Weight Gain From Antipsychotics
Iron Get the Scoop on Ferric Maltol for Iron Deficiency
Substance Use Disorder Break Down Barriers to Dispensing Buprenorphine for OUD
Transdermal Patches Cut to the Chase About Whether It’s Okay to Cut Patches
Diabetes Stay Current on Med Recommendations for Diabetes
Pneumonia Put a “CAP” on Rising Pneumonia Rates
Nutrition Share Nutrition Tips With Patients on a GLP-1 Agonist
NatMed Spotlight Emphasize Safety Concerns With Kratom